Author:
Fridlyand Jane,Simon Richard M.,Walrath Jessica C.,Roach Nancy,Buller Richard,Schenkein David P.,Flaherty Keith T.,Allen Jeff D.,Sigal Ellen V.,Scher Howard I.
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Reference49 articles.
1. Naylor, S. & Cole, T. Overview of companion diagnostics in the pharmaceutical industry. Drug Discovery World
[online]
, (2010).
2. US National Cancer Institute. Targeted cancer therapies (Fact Sheet). US National Cancer Institute
[online]
, (2012).
3. Savage, D. G. & Antman, K. H. Imatinib mesylate — a new oral targeted therapy. N. Engl. J. Med. 346, 683–693 (2002).
4. Demetri, G. D. et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N. Engl. J. Med. 347, 472–480 (2002).
5. Garnock-Jones, K. P., Keating, G. M. & Scott, L. J. Trastuzumab: a review of its use as adjuvant treatment in human epidermal growth factor receptor 2 (HER2)-positive early breast cancer. Drugs 70, 215–239 (2010).
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献